Skip to main content

10 Ethicon Physiomesh Cases Identified For Bellwether Trial

10 Ethicon Physiomesh Cases Identified For Bellwether Trial

10 Ethicon Physiomesh Cases Identified For Bellwether Trial

Introduction

According to a notice published on May 10,  a group of ten Ethicon Physiomesh lawsuits has been identified for a bellwether trial pool in the federal court system. It includes five cases selected by each side, to help gauge how juries might respond to certain evidence and testimony that will be repeated throughout the litigation. The first claims will be selected to go before a jury starting in February 2020.

J&J and its subsidiary Ethicon faces nearly 2,000 product liability lawsuits over hernia mesh complications involving abdominal pain, infection, hernia recurrence, adhesions, perforations, erosion and was removed from the market in May 2016. Following the bellwether trials, if the manufacturer fails to reach settlements or another resolution, all individual lawsuits might be remanded back to different U.S. District courts nationwide for separate trial dates in the future.

There are more than 240 Bard hernia mesh lawsuits pending in the multidistrict litigation (MDL No. 2846; In Re:  Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation) formed in the Southern District of Ohio.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!